Conclusion
Significant morbidity and mortality are attributed to LVAD thrombosis,
which are exasperated by prothrombotic conditions manifested in COVID-19
infections. LVAD thrombosis due to COVID -19 is underreported .For the
best clinical outcomes, a high level of clinical suspicion must be
present to diagnose and treat this problem effectively and efficiently.